Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications

Anesthesiology - Tập 122 Số 6 - Trang 1201-1213 - 2015
Duncan McLean1, Daniel Diaz-Gil2, Hassan Farhan3, Karim S. Ladha4, Tobias Kurth5,6,7, Matthias Eikermann5,8
1Brigham and Women's Hospital, Boston, United States
2 Inserm Research Center for Epidemiology and Biostatistics (U897)-Team Neuroepidemiology, Bordeaux, France (T.K.)
3 University of Bordeaux, College of Health Sciences, Bordeaux, France (T.K.)
4 Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts (T.K.)
5Harvard University
6Institut National de la Santé et de la Recherche Médicale
7Université de Bordeaux
8University of Duisburg-Essen

Tóm tắt

AbstractBackground:Duration of action increases with repeated administration of neuromuscular-blocking agents, and intraoperative use of high doses of neuromuscular-blocking agent may affect respiratory safety.Methods:In a hospital-based registry study on 48,499 patients who received intermediate-acting neuromuscular-blocking agents, the authors tested the primary hypothesis that neuromuscular-blocking agents are dose dependently associated with the risk of postoperative respiratory complications. In the secondary analysis, the authors evaluated the association between neostigmine dose given for reversal of neuromuscular-blocking agents and respiratory complications. Post hoc, the authors evaluated the effects of appropriate neostigmine reversal (neostigmine ≤60 μg/kg after recovery of train-of-four count of 2) on respiratory complications. The authors controlled for patient-, anesthesia-, and surgical complexity–related risk factors.Results:High doses of neuromuscular-blocking agents were associated with an increased risk of postoperative respiratory complications (n = 644) compared with low doses (n = 205) (odds ratio [OR], 1.28; 95% CI, 1.04 to 1.57). Neostigmine was associated with a dose-dependent increase in the risk of postoperative respiratory complications (OR, 1.51; 95% CI, 1.25 to 1.83). Post hoc analysis revealed that appropriate neostigmine reversal eliminated the dose-dependent association between neuromuscular-blocking agents and respiratory complications (for neuromuscular-blocking agent effects with appropriate reversal: OR, 0.98; 95% CI, 0.63 to 1.52).Conclusions:The use of neuromuscular-blocking agents was dose dependently associated with increased risk of postoperative respiratory complications. Neostigmine reversal was also associated with a dose-dependent increase in the risk of respiratory complications. However, the exploratory data analysis suggests that the proper use of neostigmine guided by neuromuscular transmission monitoring results can help eliminate postoperative respiratory complications associated with the use of neuromuscular-blocking agents.

Từ khóa


Tài liệu tham khảo

2008, An estimation of the global volume of surgery: A modelling strategy based on available data., Lancet, 372, 139, 10.1016/S0140-6736(08)60878-8

2003, Laryngeal morbidity and quality of tracheal intubation: A randomized controlled trial., Anesthesiology, 98, 1049, 10.1097/00000542-200305000-00005

1977, The effects of anesthetic drugs and disease on the chemical regulation of ventilation., Int Anesthesiol Clin, 15, 1, 10.1097/00004311-197715020-00001

2012, Residual neuromuscular blockade affects postoperative pulmonary function., Anesthesiology, 117, 1234, 10.1097/ALN.0b013e3182715b80

2010, Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block., Anesth Analg, 111, 120, 10.1213/ANE.0b013e3181da832d

2004, Hospital costs associated with surgical complications: A report from the private-sector National Surgical Quality Improvement Program., J Am Coll Surg, 199, 531, 10.1016/j.jamcollsurg.2004.05.276

2005, Determinants of long-term survival after major surgery and the adverse effect of postoperative complications., Ann Surg, 242, 326, 10.1097/01.sla.0000179621.33268.83

2011, Independent predictors and outcomes of unanticipated early postoperative tracheal intubation after nonemergent, noncardiac surgery., Anesthesiology, 115, 44, 10.1097/ALN.0b013e31821cf6de

2006, Preoperative pulmonary risk stratification for noncardiothoracic surgery: Systematic review for the American College of Physicians., Ann Intern Med, 144, 581, 10.7326/0003-4819-144-8-200604180-00009

2007, Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium., Anaesthesia, 62, 12, 10.1111/j.1365-2044.2006.04862.x

2010, Repeat dosing of rocuronium 1.2 mg/kg after reversal of neuromuscular block by sugammadex 4.0 mg/kg in anaesthetized healthy volunteers: A modelling-based pilot study., Br J Anaesth, 105, 487, 10.1093/bja/aeq167

1995, Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients., Br J Anaesth, 74, 709, 10.1093/bja/74.6.709

2013, Development and validation of a score for prediction of postoperative respiratory complications., Anesthesiology, 118, 1276, 10.1097/ALN.0b013e318293065c

2012, Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: Prospective propensity score matched cohort study., BMJ, 345, e6329, 10.1136/bmj.e6329

1995, The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia., Anesthesiology, 82, 1139, 10.1097/00000542-199505000-00008

1995, Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids., Br J Anaesth, 75, 37, 10.1093/bja/75.1.37

1986, Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens., Anesthesiology, 64, 72, 10.1097/00000542-198601000-00011

2000, The origin of the “ideal” body weight equations., Ann Pharmacother, 34, 1066, 10.1345/aph.19381

2011, Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients., Br J Clin Pharmacol, 71, 34, 10.1111/j.1365-2125.2010.03803.x

2005, Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data., Med Care, 43, 1130, 10.1097/01.mlr.0000182534.19832.83

2006, Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section., Br J Anaesth, 96, 95, 10.1093/bja/aei265

2013, A comparison of the reliability of smartphone apps for opioid conversion., Drug Saf, 36, 111, 10.1007/s40264-013-0015-0

2004, Nomogram to estimate age-related MAC., Br J Anaesth, 93, 288, 10.1093/bja/aeh186

2014, Hospital readmission after noncardiac surgery: The role of major complications., JAMA Surg, 149, 439, 10.1001/jamasurg.2014.4

2013, Effect of cancer surgery complexity on short-term outcomes, risk predictions, and hospital comparisons., J Am Coll Surg, 217, 685, 10.1016/j.jamcollsurg.2013.05.015

2010, Predictors of major complications after laparoscopic cholecystectomy: Surgeon, hospital, or patient?, J Am Coll Surg, 211, 73, 10.1016/j.jamcollsurg.2010.02.050

2014, Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: A prospective study., Anesthesiology, 121, 959, 10.1097/ALN.0000000000000440

2011, The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring., Anesth Analg, 112, 63, 10.1213/ANE.0b013e3181fdf889

1992, Anaesthetic practice and postoperative pulmonary complications., Acta Anaesthesiol Scand, 36, 812, 10.1111/j.1399-6576.1992.tb03570.x

2005, Impact of anesthesia management characteristics on severe morbidity and mortality., Anesthesiology, 102, 257, 10.1097/00000542-200502000-00005

1978, Death attributable to anaesthesia. A 10-year survey (1967–1976)., Br J Anaesth, 50, 1041, 10.1093/bja/50.10.1041

1994, Critical respiratory events in the postanesthesia care unit. Patient, surgical, and anesthetic factors., Anesthesiology, 81, 410, 10.1097/00000542-199408000-00020

2003, Predictors of survival following cardiac arrest in patients undergoing noncardiac surgery: A study of 518,294 patients at a tertiary referral center., Anesthesiology, 99, 259, 10.1097/00000542-200308000-00006

2001, Postoperative residual block after intermediate-acting neuromuscular blocking drugs., Anaesthesia, 56, 312, 10.1046/j.1365-2044.2001.01921.x

2005, Residual paralysis at the time of tracheal extubation., Anesth Analg, 100, 1840, 10.1213/01.ANE.0000151159.55655.CB

2010, Residual paralysis after emergence from anesthesia., Anesthesiology, 112, 1013, 10.1097/ALN.0b013e3181cded07

2013, Postoperative respiratory muscle dysfunction: Pathophysiology and preventive strategies., Anesthesiology, 118, 961, 10.1097/ALN.0b013e318288834f

2013, A trial of intraoperative low-tidal-volume ventilation in abdominal surgery., N Engl J Med, 369, 428, 10.1056/NEJMoa1301082

2006, Cellular inflammatory response and clinical outcome in cardiac surgery., Curr Opin Anaesthesiol, 19, 65, 10.1097/01.aco.0000192773.86656.bf

2013, Fluid management in thoracic surgery., Curr Opin Anaesthesiol, 26, 31, 10.1097/ACO.0b013e32835c5cf5

2010, Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge., Br J Anaesth, 105, 304, 10.1093/bja/aeq157

2005, Fade of pulmonary function during residual neuromuscular blockade., Chest, 127, 1703, 10.1378/chest.127.5.1703

2007, The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade., Am J Respir Crit Care Med, 175, 9, 10.1164/rccm.200512-1862OC

2006, Residual neuromuscular blockade: Incidence, assessment, and relevance in the postoperative period., Minerva Anestesiol, 72, 97

2008, Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit., Anesth Analg, 107, 130, 10.1213/ane.0b013e31816d1268

2000, The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: Pharyngeal videoradiography and simultaneous manometry after atracurium., Anesthesiology, 92, 977, 10.1097/00000542-200004000-00014

2000, Requirements for muscle relaxants during radical retropubic prostatectomy., Anesthesiology, 93, 1392, 10.1097/00000542-200012000-00008

2010, Residual neuromuscular block: Lessons unlearned. Part II: Methods to reduce the risk of residual weakness., Anesth Analg, 111, 129, 10.1213/ANE.0b013e3181da8312

2003, Evidence-based practice and neuromuscular monitoring: It’s time for routine quantitative assessment., Anesthesiology, 98, 1037, 10.1097/00000542-200305000-00002

2014, Residual neuromuscular block should, and can, be a “never event.”, Anesth Analg, 118, 691, 10.1213/ANE.0000000000000090

2012, [Monitoring of neuromuscular block by acceleromyography: Concepts, applications and limits of use]., Ann Fr Anesth Reanim, 31, 922, 10.1016/j.annfar.2012.08.015

2013, A survey of the management of neuromuscular blockade monitoring in Australia and New Zealand., Anaesth Intensive Care, 41, 374, 10.1177/0310057X1304100316

1992, Reversal of neuromuscular blockade., Anesthesiology, 77, 785, 10.1097/00000542-199210000-00025

2012, A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery., Anaesthesia, 67, 991, 10.1111/j.1365-2044.2012.07197.x

2013, Neostigmine reversal doesn’t improve postoperative respiratory safety., BMJ, 346, f1460, 10.1136/bmj.f1460

2013, [Anticholinesterases; peripheral and central effects]., Masui, 62, 19

2009, Control of perioperative muscle strength during ambulatory surgery., Curr Opin Anaesthesiol, 22, 730, 10.1097/ACO.0b013e328331d545

2009, Antagonism of non-depolarising neuromuscular block: Current practice., Anaesthesia, 64, 22, 10.1111/j.1365-2044.2008.05867.x

Thông tin
Thông tin xuất bản

Anesthesiology

Tập 122 Số 6

1201-1213

Thông tin tác giả